Search

everythinglearnresearchcommunity

for

Search:↓

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

CMV infection increases the risk of GvHD after bone marrow transplants.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Stem cells help control the immune response to improve wound healing.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

PDCD4 is important for controlling skin cell growth and healing.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

PCFCL may have unrecognized subtypes and needs more research.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Blocking certain proteins on immune cells may help treat alopecia areata.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Finasteride increases CD8+ T cells in BPH tissues.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

CS12192 effectively treats alopecia areata with better safety than current options.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.